ASCO Clinical Challenge: Are You an ASCO 2019 Expert?
The lights are out, the banners down, and the overflow rooms empty as the American Society of...
Read More
ASCO 2019
ASCO VIDEO: Richard L. Schilsky, MD
Senior Vice President and Chief Medical Officer, ASCO
Read More
ASCO VIDEO: Debu Tripathy, MD
Study author: MONALEESA-7; University of Texas MD Anderson Cancer Center
Read More
ASCO 2019: It Really Is All About the Targets
A quick run through the highlights and the headlines from the world’s biggest cancer meeting....
Read More
ASCO 2019: Investigational AKT Inhibitor Holds Promise in ER+ Disease
Potency is clear, but for capivasertib, toxicity is an issue CHICAGO – In a small study of...
Read More
ASCO 2019: Test All Triple Negative Breast Cancer Patients for PD-L1
Latest analysis from IMpassion trial confirms need for testing CHICAGO— One of the repeated themes...
Read More
ASCO: Palbociclib Extends PFS in Young Women with HR+/HER2 Metastatic Breast Cancer
Korean study is first to show palbociclib benefit in premenopausal women CHICAGO—A second trial of...
Read More
ASCO 2019: NALA III Results Find ‘Modest Benefit’ for Neratinib Plus Capecitabine in Metastatic Breast Cancer
Findings hint at CNS benefit for neratinib CHICAGO —A phase III trial comparing neratinib plus...
Read More
ASCO 2019: A Metavivor Offers Advice to Clinicians Treating Metastatic Breast Cancer
‘Don’t call my disease chronic.’ By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO — Kelli Davis...
Read More
